Skip to main content
Premium Trial:

Request an Annual Quote

Joseph Vallner, Tom Mino, Tom Humphreys, Essam Sheta

Premium

Lumera has appointed Joseph Vallner to its board of directors. Vallner is president and chief operating officer of Cell Genesys. Prior to joining Cell Genesys in 1999, he held positions at SEQUUS Pharmaceuticals, Syntex, and G.D. Searle. Vallner was also an associate professor of pharmaceutics at the University of Georgia.

Tom Mino, president and CEO of Lumera, said in a statement that Vallner's "operational expertise in bioscience will help us to increase productivity as we grow our proteomics business."


Tom Humphreys, professor of cell and molecular biology at the John A. Burns School of Medicine at the University of Hawaii at Manoa, has been tapped to lead research initiatives for the university's new Center for Genomics, Proteomics and Bioinformatics.

Humphreys has been on the faculty at Manoa for 34 years. During that time, he organized the first recombinant DNA lab in Hawaii, led a reorganization of the UH Cancer Research Center of Hawaii, established the graduate program in cell and molecular biology and founded Hawaii Biotech, the state's biotech venture. He has accepted a three-year appointment as director of the center, effective July 1.


Essam Sheta, director of biochemistry at Power3 Medical Products, has been named to the American Institute of Biological Sciences' review panel for grant proposals related to Parkinson's disease.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.